Literature DB >> 6602848

Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.

T A Luger, J A Charon, M Colot, M Micksche, J J Oppenheim.   

Abstract

Human epidermal cell thymocyte-activating factor (ETAF) derived from either normal epidermal cells or a squamous cell carcinoma cell line has recently been shown to be a low m.w. protein that is indistinguishable from human macrophage-derived interleukin 1 (IL 1). As with human IL 1, human ETAF elutes from Sephadex S-200 gel in two major peaks at m.w. 70,000 to 40,000 and m.w. 25,000 to 12,000. Rechromatography of the higher m.w. fraction of ETAF yielded some of the lower m.w. activity, and chromatofocusing of high m.w. ETAF yielded the same three isoelectric points as the lower m.w. ETAF. Partially purified human ETAF as well as IL 1 were chemotactic for polymorphonuclear and mononuclear leukocytes. In addition, exposure of PMN to ETAF stimulated increased metabolic activity as demonstrated by greater reduction of intracellular nitroblue tetrazolium. Therefore, this study lends further support for an important role of ETAF in the pathogenesis of inflammatory skin diseases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602848

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Cytokines: past, present, and future.

Authors:  J J Oppenheim
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

2.  Anti-inflammatory activity of IFN-beta in carrageenan-induced pleurisy in the mouse.

Authors:  P Ghiara; M Bartalini; A Tagliabue; D Boraschi
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

3.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

4.  Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.

Authors:  J Schnyder; T Hunziker; M Strasser; B Richardson; A Krebs
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 5.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

6.  Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors:  B Henderson; E R Pettipher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

7.  Attracting Attention: Discovery of IL-8/CXCL8 and the Birth of the Chemokine Field.

Authors:  Bethany B Moore; Steven L Kunkel
Journal:  J Immunol       Date:  2019-01-01       Impact factor: 5.422

8.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin.

Authors:  S J Foster; D M Aked; J M Schröder; E Christophers
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

10.  Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.

Authors:  Y Ozaki; T Ohashi; A Minami; S Nakamura
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.